Neil Drake - Net Worth and Insider Trading
Neil Drake Net Worth
The estimated net worth of Neil Drake is at least $2,730 dollars as of 2024-11-13. Neil Drake is the VP Research and Development of Obalon Therapeutics Inc and owns about 895 shares of Obalon Therapeutics Inc (OBLN) stock worth over $2,730. Details can be seen in Neil Drake's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Neil Drake has not made any transactions after 2018-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Neil Drake
Neil Drake Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Neil Drake owns 2 companies in total, including Obalon Therapeutics Inc (OBLN) , and Reshape Lifesciences Inc (RSLS) .
Click here to see the complete history of Neil Drake’s form 4 insider trades.
Insider Ownership Summary of Neil Drake
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
OBLN | Obalon Therapeutics Inc | 2019-01-02 | VP Research and Development |
RSLS | Reshape Lifesciences Inc | 2017-02-01 | VP of Research and Development |
Neil Drake Latest Holdings Summary
Neil Drake currently owns a total of 1 stock. Neil Drake owns 895 shares of Obalon Therapeutics Inc (OBLN) as of March 15, 2018, with a value of $2,730.
Latest Holdings of Neil Drake
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
OBLN | Obalon Therapeutics Inc | 2018-03-15 | 895 | 3.05 | 2,730 |
Holding Weightings of Neil Drake
Neil Drake Form 4 Trading Tracker
According to the SEC Form 4 filings, Neil Drake has made a total of 0 transactions in Obalon Therapeutics Inc (OBLN) over the past 5 years. The most-recent trade in Obalon Therapeutics Inc is the acquisition of 167 shares on March 15, 2018, which cost Neil Drake around $19,800.
Insider Trading History of Neil Drake
- 1
Neil Drake Trading Performance
GuruFocus tracks the stock performance after each of Neil Drake's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Neil Drake is -38.65%. GuruFocus also compares Neil Drake's trading performance to market benchmark return within the same time period. The performance of stocks bought by Neil Drake within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Neil Drake's insider trading performs compared to the benchmark.
Performance of Neil Drake
Neil Drake Ownership Network
Ownership Network List of Neil Drake
Ownership Network Relation of Neil Drake
Neil Drake Owned Company Details
What does Obalon Therapeutics Inc do?
Who are the key executives at Obalon Therapeutics Inc?
Neil Drake is the VP Research and Development of Obalon Therapeutics Inc. Other key executives at Obalon Therapeutics Inc include director & President & CEO & Exec Chairman Andrew P Rasdal , Chief Financial Officer Nooshin Hussainy , and Chief Technology Officer Mark Brister .
Obalon Therapeutics Inc (OBLN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Obalon Therapeutics Inc (OBLN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Obalon Therapeutics Inc (OBLN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Obalon Therapeutics Inc (OBLN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Obalon Therapeutics Inc Insider Transactions
Neil Drake Mailing Address
Above is the net worth, insider trading, and ownership report for Neil Drake. You might contact Neil Drake via mailing address: 12020 Least Tern Court, San Diego Ca 92129.